Efficacy and safety of dupilumab in antihistamine-refractory, omalizumab-naïve chronic spontaneous urticaria: A systematic review. // JAAD Reviews. – URL: https://www.sciencedirect.com/science/article/pii/S2950198926000450?dgcid=rss_sd_all
Efficacy and safety of dupilumab in antihistamine-refractory, omalizumab-naïve chronic spontaneous urticaria: A systematic review. JAAD Reviews. https://www.sciencedirect.com/science/article/pii/S2950198926000450?dgcid=rss_sd_all
“Efficacy and safety of dupilumab in antihistamine-refractory, omalizumab-naïve chronic spontaneous urticaria: A systematic review.” JAAD Reviews.
@article{article116935,
title = {Efficacy and safety of dupilumab in antihistamine-refractory, omalizumab-naïve chronic spontaneous urticaria: A systematic review},
journal = {JAAD Reviews},
url = {https://www.sciencedirect.com/science/article/pii/S2950198926000450?dgcid=rss_sd_all}
}